Cargando…
SUN-094 Long-Term Safety and Efficacy of Leuprorelin in Treating Central Precocious Puberty: A Large, Open-Label, Multicenter, Phase IV Study in China
BACKGROUND: Leuprorelin (Enantone®) is a gonadotropin-releasing hormone (GnRH) analogue used worldwide to treat central precocious puberty (CPP). This clinical trial aimed to evaluate the long-term safety and efficacy of leuprorelin in treating Chinese CPP children. Methods: This is the first, prosp...
Autores principales: | Luo, Xiaoping, Hou, Ling, Zhong, Yan, Yang, Yu, Li, Pin, Qiu, Wenjuan, Liu, Ying, Luo, Feihong, Hu, Yuhua, Wang, Qing, Du, Hongwei, Fu, Junfen, Wang, Winston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208757/ http://dx.doi.org/10.1210/jendso/bvaa046.571 |
Ejemplares similares
-
An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children
por: Luo, Xiaoping, et al.
Publicado: (2021) -
Efficacy and Safety of Domestic Leuprorelin in Girls with Idiopathic Central Precocious Puberty: A Multicenter, Randomized, Parallel, Controlled Trial
por: Li, Wen-Jing, et al.
Publicado: (2015) -
SUN-LB18 Serum 25-Hydroxyvitamin D Is Not Associated With the Type of Central Precocious Puberty in Girls
por: Xu, Liya, et al.
Publicado: (2020) -
Precocious Puberty: Types, Pathogenesis and Updated Management
por: Alghamdi, Ahmed
Publicado: (2023) -
MON-069 Uncontrolled Central Precocious Puberty Patient Against GnRH Agonist, After Showing Granuloma Formation and Sterile Abscess to Both Leuprorelin Acetate and Triptorelin Actate
por: Kim, Dae Hyun, et al.
Publicado: (2020)